SeQuent Please vs. Pantera Lux drug coated balloon angioplasty in real life: Results from the Dusseldorf DCB registry

被引：13
作者：
Assadi-Schmidt, Athena [1 ]
Mohring, Annemarie [1 ]
Liebsch, Eva [1 ]
Dannenberg, Lisa [1 ]
Achilles, Alina [1 ]
Poehl, Martin [1 ]
Afzal, Shazia [1 ]
Veulemans, Verena [1 ]
Horn, Patrick [1 ]
Sansone, Roberto [1 ]
Boenner, Florian [1 ]
Levkau, Bodo [2 ]
Kelm, Malte [1 ]
Zeus, Tobias [1 ]
Polzin, Amin [1 ]
机构：
[1] Heinrich Heine Univ, Med Ctr Dusseldorf, Div Cardiol Pulmonol & Vasc Med, Dusseldorf, Germany
[2] Univ Duisburg Essen, Univ Hosp Essen, West German Heart & Vasc Ctr, Inst Pathophysiol, Essen, Germany
来源：
INTERNATIONAL JOURNAL OF CARDIOLOGY | 2017年 / 231卷
关键词：
Coronary intervention; Drug-coated balloon; Drug-eluting balloon; Paclitaxel; Registry; TREATMENT PLATELET REACTIVITY; DIPYRONE METAMIZOLE; CLINICAL-OUTCOMES; ASPIRIN; CLOPIDOGREL; RESTENOSIS;
D O I：
10.1016/j.ijcard.2016.12.022
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Background: In-stent restenosis (ISR) is still a major concern in interventional cardiology. Drug coated balloon (DCB) angioplasty has been shown to be a promising option in treatment of ISR. However heterogeneity of different DCBs in suppression of neointimal growth has been described in a porcine model of coronary ISR. Therefore, in this registry analysis, we compared two frequently used paclitaxel eluting DCBs, the SeQuent Please and the Pantera Lux DCB. Methods: 571 patients were treated with DCB angioplasty at the Heinrich-Heine University Dusseldorf between 2009 and 2012. Follow-up was conducted during ambulatory care at our department. Major adverse cardiac events (death, myocardial infarction [MI] and target lesion revascularization) were registered during hospitalization and follow-up. Results: Patient characteristics, prior diseases, clinical presentation, ejection fraction, procedural success and lost-for-follow-up did not differ between patients treated with the SeQuent Please and. The Pantera Lux DCB. MACE during hospital course were similar as well (Pantera Lux: 6 patients [1.6%] vs. SeQuent (R) Please: 3 patients [1.5%], relative risk 1.06, 95% confidence interval 0.3-4.2, P = 0.93). Event free survival was significantly longer in patients treated with the Pantera Lux DCB as compared to SeQuent Please DCB (Hazard ratio: 0.65, 95% confidence interval 0.43-0.98; P value of log-rank test: 0.0405). Conclusion: MACE free survival was longer in Pantera Lux DCB treated patients as compared to SeQuent Please treated patients. This finding has to be confirmed in future clinical trials. (C) 2016 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码：68 / 72
页数：5
相关论文
共 20 条
[1]   Differential Effects of Omeprazole and Pantoprazole on the Pharmacodynamics and Pharmacokinetics of Clopidogrel in Healthy Subjects: Randomized, Placebo-Controlled, Crossover Comparison Studies [J].
Angiolillo, D. J. ;
Gibson, C. M. ;
Cheng, S. ;
Ollier, C. ;
Nicolas, O. ;
Bergougnan, L. ;
Perrin, L. ;
LaCreta, F. P. ;
Hurbin, F. ;
Dubar, M. .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2011, 89 (01) :65-74
[2]   Role of intimal hyperplasia and arterial remodeling after balloon angioplasty - An experimental study in the atherosclerotic rabbit model [J].
Guzman, LA ;
Mick, MJ ;
Arnold, AM ;
Forudi, F ;
Whitlow, PL .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1996, 16 (03) :479-487
[3]   Late Restenosis After Paclitaxel-Coated Balloon Angioplasty Occurs in Patients With Drug-Eluting Stent Restenosis [J].
Habara, Seiji ;
Kadota, Kazushige ;
Shimada, Takenobu ;
Ohya, Masanobu ;
Amano, Hidewo ;
Izawa, Yu ;
Kubo, Shunsuke ;
Hyodo, Yusuke ;
Otsuru, Suguru ;
Hasegawa, Daiji ;
Tada, Takeshi ;
Tanaka, Hiroyuki ;
Fuku, Yasushi ;
Goto, Tsuyoshi ;
Mitsudo, Kazuaki .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 66 (01) :14-22
[4]   Comparative assessment of drug-eluting balloons in an advanced porcine model of coronary restenosis [J].
Joner, Michael ;
Byrne, Robert A. ;
Lapointe, Jean-Martin ;
Radke, Peter W. ;
Bayer, Gerd ;
Steigerwald, Kristin ;
Wittchow, Eric .
THROMBOSIS AND HAEMOSTASIS, 2011, 105 (05) :864-872
[5]   Aspirin Treatment and Outcomes After Percutaneous Coronary Intervention Results of the ISAR-ASPI Registry [J].
Mayer, Katharina ;
Bernlochner, Isabell ;
Braun, Siegmund ;
Schulz, Stefanie ;
Orban, Martin ;
Morath, Tanja ;
Cala, Lisena ;
Hoppmann, Petra ;
Schunkert, Heribert ;
Laugwitz, Karl-Ludwig ;
Kastrati, Adnan ;
Sibbing, Dirk .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 64 (09) :863-871
[6]   Antiplatelet effects of aspirin in chronic kidney disease patients [J].
Polzin, A. ;
Dannenberg, L. ;
Sansone, R. ;
Levkau, B. ;
Kelm, M. ;
Hohlfeld, T. ;
Zeus, T. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2016, 14 (02) :375-380
[7]   Antiplatelet effects of clopidogrel and aspirin after interventional patent foramen ovale/atrium septum defect closure [J].
Polzin, Amin ;
Dannenberg, Lisa ;
Popp, Valerie-Sophia ;
Kelm, Malte ;
Zeus, Tobias .
PLATELETS, 2016, 27 (04) :317-321
[8]   Platelet reactivity in MitraClip patients [J].
Polzin, Amin ;
Afzal, Shazia ;
Balzer, Jan ;
Rassaf, Tienush ;
Kelm, Malte ;
Zeus, Tobias .
VASCULAR PHARMACOLOGY, 2016, 77 :54-59
[9]   Prevention of dipyrone (metamizole) induced inhibition of aspirin antiplatelet effects [J].
Polzin, Amin ;
Richter, Stefan ;
Schroer, Karsten ;
Rassaf, Tienush ;
Merx, Marc W. ;
Kelm, Malte ;
Hohlfeld, Thomas ;
Zeus, Tobias .
THROMBOSIS AND HAEMOSTASIS, 2015, 114 (01) :87-95
[10]   Impaired clopidogrel antiplatelet effects and age: Young patients at risk [J].
Polzin, Amin ;
Kelm, Malte ;
Zeus, Tobias .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2015, 187 :216-218
12